Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schulman

Showing results (71-80 of 424) with videos related to

Pageof 43
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Continuous infusion instead of bolus injections of factor concentrate?S Schulman, U Martinowitz
Thrombosis and Haemostasis|April 1, 1996
The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Duration of Anticoagulation (DURAC) Trial Study GroupS Schulman, B Wiman
The New England Journal of Medicine|June 30, 2000
Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation TrialS Schulman, P Lindmarker
Journal of Thrombosis and Haemostasis : JTH|March 6, 2004
Vitamin K antagonists and cancer: rebuttalS Schulman, P Lindmarker
Scandinavian Journal of Infectious Diseases|January 1, 1990
Antibodies against hepatitis C in a population of Swedish haemophiliacs and heterosexual partnersS Schulman, L Grillner
The American Journal of Cardiology|November 14, 1997
Relation of changes in left ventricular peak filling rate during exercise to exercise performance in systemic hypertension and in healed myocardial infarctionG Geskin, D S Schulman
Journal of Thrombosis and Haemostasis : JTH|January 12, 2010
Antithrombotic drugs in coronary artery disease: risk benefit ratio and bleedingS Schulman, F A Spencer
Lancet (London, England)|October 20, 1984
Wright's b determinant, monoclonal antibodies, and Plasmodium falciparum merozoite invasionS Schulman, J P Vanderberg
Journal of Physics. Condensed Matter : an Institute of Physics Journal|January 29, 2015
Low temperature delayed recombination and trap tunnelingE Mihóková, L S Schulman
American Journal of Therapeutics|September 19, 2002
Adenosine 5'-triphosphate axis in obstructive airway diseasesAmir Pelleg, Edward S Schulman
Pageof 43

Showing results (71-80 of 424) with videos related to

Sort By:
Pageof 43
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Continuous infusion instead of bolus injections of factor concentrate?S Schulman, U Martinowitz
Thrombosis and Haemostasis|April 1, 1996
The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Duration of Anticoagulation (DURAC) Trial Study GroupS Schulman, B Wiman
The New England Journal of Medicine|June 30, 2000
Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation TrialS Schulman, P Lindmarker
Journal of Thrombosis and Haemostasis : JTH|March 6, 2004
Vitamin K antagonists and cancer: rebuttalS Schulman, P Lindmarker
Scandinavian Journal of Infectious Diseases|January 1, 1990
Antibodies against hepatitis C in a population of Swedish haemophiliacs and heterosexual partnersS Schulman, L Grillner
The American Journal of Cardiology|November 14, 1997
Relation of changes in left ventricular peak filling rate during exercise to exercise performance in systemic hypertension and in healed myocardial infarctionG Geskin, D S Schulman
Journal of Thrombosis and Haemostasis : JTH|January 12, 2010
Antithrombotic drugs in coronary artery disease: risk benefit ratio and bleedingS Schulman, F A Spencer
Lancet (London, England)|October 20, 1984
Wright's b determinant, monoclonal antibodies, and Plasmodium falciparum merozoite invasionS Schulman, J P Vanderberg
Journal of Physics. Condensed Matter : an Institute of Physics Journal|January 29, 2015
Low temperature delayed recombination and trap tunnelingE Mihóková, L S Schulman
American Journal of Therapeutics|September 19, 2002
Adenosine 5'-triphosphate axis in obstructive airway diseasesAmir Pelleg, Edward S Schulman
Pageof 43